top of page
A Closer Look

RESEARCH GRANT AWARDS

AWARDS LIST.

Totals by Year

2024 - 1,139,000
2023 - $891,364

2022 - $1,199,966

2021 - $749,812

2020 - $630,000

2019 - $690,000

2018 - $750,000

2017 - $747,772

2016 - $720,000

2015 - $840,000

2014 - $810,000

2013 - $808,500

2012 - $720,000

2011 - $599,780

2010 - $438,000

2009 - $435,000

2008 - $619,993

2007 - $232,600

2006 - $384,551

Amounts flagged (*) below are funded by Cancer League of Colorado and a generous matching grant from MDC/Richmond American Homes Foundation

Rebecca Schweppe, PhD

Cooperative Src and MAP Kinase Signaling in Thyroid Cancer

 $     30,000

2018

Scott Cramer, PhD and James Costello, PhD

Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7

 $     60,000

2018

Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD

Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma

 $     60,000

2018

Nicholas Forman, MD

Characterization of heterogeneous tumor subpopulations in childhood ependymoma

 $     30,000

2018

Daniel V. LaBarbera, PhD and Wells A. Messersmith, MD

Patient Derived Tumor Organoids for Personalized and Targeted Colorectal Cancer Therapeutics

60,000

2017

Jung-Jae Lee, PhD

Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer

29,835

2017

Darinee Tippimanchai, PhD

Targeting IL17 in Kras mutant lung cancer

30,000

2017

Jenna Sopfe, MD

Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population

29,961

2017

John Tentler, PhD

Cancer Research Summer Fellowship Program

30,000

2017

Rebecca Schweppe, PhD

Targeting FAK and Src in Thyroid Cancer

30,000

2017

Matthew J. Sikora, PhD

Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma

30,000

2017

Jing H. Wang, MD, PhD

Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses

30,000

2017

Kasey Couts, PhD

Improving targeted therapy in melanomas with BRAF fusions

30,000

2017

Britta Jacobsen, PhD

Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer

30,000

2017

Eric Clambey, PhD

High-dimensional analysis of effector T cell mechanisms in lung cancer

30,000

2017

Heide L. Ford, PhD

Role of Six2 in mediating late stage metastasis

30,000

2017

Paul Jedlicka, MD, PhD

The epigenetic modifiers PHF2 and PhF8 in Ewing Sarcoma

30,000

2017

Changwei Liu, PhD

Validating USP35 as an anticancer drug target

30,000

2017

Hyunmin Kim, PhD

Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer

30,000

2017

David Bentley, PhD

Deregulation of mRNA 3′ end formation in breast cancer

30,000

2017

Dan Theodorescu, MD, PhD

Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients

30,000

2017

Todd Hankinson, MD, MBA

Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression

27,976

2017

Sana Karam, MD, PhD

Enhancing the Effects of Immune Checkpoint Blockade with Radiation Therapy in Head and Neck Cancer

30,000

2017

Amanda C. Winters, MD, PhD

Validating CD123 as a Leukemia Stem Cell Marker and Therapeutic Target in Pediatric AML

30,000

2017

James Costello, PhD

Measuring chromosome-conformation abnormalities within a single cancer cell

30,000

2017

Traci R. Lyons, PhD and      Beth Taburini, PhD

Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity

60,000

2017

James DeGregori, PhD

Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer

30,000

2017

Isabel Schlaepfer, PhD

Role of androgens on lipid catabolism in prostate cancer

30,000

2016

Scott Alper, PhD and Daniel Pollyea, MD, MS

Splicing gene mutations and infection in MDS patients

30,000

2016

Lauren Fishbein, MD, PhD

Investigating the role of MAML3 in neuroendocrine tumorigenesis

30,000

2016

Melanie Vincent, PhD

Targeting Eya2 to inhibit c-Myc driven Medulloblastoma Tumor

30,000

2016

William Robinson, MD, PhD

CARD10 and NFkB signaling in melanoma: Implications for immunotherapy

30,000

2016

S. Gail Eckhardt, MD & Aik Choon Tan, PhD

Exploiting Patient Derived Cancer Models for Novel Immunotherapy Regimens

60,000

2016

Lynn Heasley, PhD and Raphael Nemenoff, PhD

Identification of TME-Derived Pathways for Co-Targeting in FGFR1-Dependent Lung Cancers

60,000

2016

Howard Li, MD

Mechanisms of Resistance to T Cell-Mediated Immunotherapy in Non-Small Cell Lung Cancer

30,000

2016

Christian Young, PhD

Targeting paracrine stromal factors induced by P13K inhibitor therapy in head and neck cancer

30,000

2016

Yuwen Zhu, PhD

Targeting the novel immune checkpoint CD112R for cancer therapy

30,000

2016

Dohun Pyeon, PhD

Role of Antitumor Chemokines in Clearance of Head and Neck Cancer

30,000

2016

Diana Cittelly, PhD

Role of TRKB/BDNF axis in brain metastatic breast cancer

30,000

2016

Shi-Long Lu, PhD and John Song, MD

Role of microRNA methylation and its application as a biomarker in head and neck cancer

60,000

2016

James DeGregori, PhD

Examining oncogenic clonal expansions in the context of aging

30,000

2016

Arthur Gutierrez-Hartman, MD

Elucidating the Mechanism by which ESE-1 Controls Estrogen Mediated Tumorigenesis in HER2 + ER + Luminal B Human Breast Cancer

30,000

2016

John Tentler, PhD

Cancer Research Summer Fellowship Program

30,000

2016

Joseph Sottnik, PhD

Therapeutic targeting of organ specific tumor growth and metastases through functional genomics

30,000

2016

Matthew Galbraith, PhD

Novel genes mediating cancer cell survival and proliferation in hypoxic conditions

30,000

2016

Christopher Porter, MD

The Role of ETV6 in B lymphopoiesis

30,000

2016

Tamara Terzian, PhD

p53 in melanoma

30,000

2016

Britta Jacobsen, PhD

Examining the role of Mucin-2 in breast cancer

30,000

2016

James Costello, PhD

Integrating Transcriptional Regulatory And Metabolic Networks To Characterize Bladder Cancer Cellular Response to Chemotherapies

       $30,000

2015

Neil Box

Determining the utility of UV photography as a quantitative tool for evaluating sun exposure history of children and adolescents

       $60,000

2015

John Tentler, PhD

Cancer Research Summer Fellowship Program

       30,000

2015

Mayumi Fujita, MD, PhD

Homozygously deleted chromosomal changes in metastatic melanoma

       $60,000

2015

Raul Torres, PhD

Tumor-derived LPA immune suppression of CD8 T cell tumor immunity

       $30,000

2015

Elizabeth Wellberg, PhD

The role of the Androgen Receptor in obesity-associated postmenopausal breast cancer

       $30,000

2015

Anna Capasso, MD

Combination Therapies for Young Patients with late state colorectal cancer

       $30,000

2015

Dr. MoumitaGhosh

A novel preclinical model to test Iloprost and PPAR delta antagonist in lung cancer chemoprevention

       $30,000

2015

Sana Karam, MD, PhD

Role of EphB4 in radiosensitization in PDX model of head and neck cancer

       $30,000

2015

Dan Theodorescu

Identification and characterization of GON4L as a novel regulator of oncogene CD24 in bladder cancer

       $30,000

2015

Robert Annett, PhD

Novel Assessment of Neuropsychological Difficulties in Children (NAND-Child)

       $60,000

2015

Steve Anderson, PhD

Targeting breast cancer stem cells by inhibiting glucose metabolism

      $60,000

2015

Elan Eisenmesser, PhD

The anti-cancer mechanism of Il-37

       $30,000

2015

Laurel L. Lenz, PhD

Activation of NK cells for immunotherapy of lung tumors

       $30,000

2015

Jennifer Hintzsche, PhD

Identifying Molecular Targets in Melanoma Resistant to Braf/Mek Combination Therapy

       $30,000

2015

Margaret Wierman, MD

Role of Mammalian Sterile 20 like kinase 4 (MSTA) in Pediatric Brain Cancer

       $60,000

2015

Katja Kiseljak-Vassiliades, DO

Approaches to Targeted Therapy in Adrenal Carcinogenesis

       $60,000

2015

Karen Ryall, PhD

Systems analysis of EGFR-inhibitor induced kinome reprograming and EMT in non-small cell lung cancer

       30,000

2015

Andrew Thorburn, PhD

Selective targeting of drug-induced autophagy to improve cancer therapy

      $ 60,000

2015

MarkGregory, PhD

Redox-targeted therapy for the treatment of FLT3 mutated leukemia

       $30,000

2015

Jeffery Kieft, PhD

How does miRNA modulation of mRNA structure regulate production of a pro-tumor chemokine receptor?

       $30,000

2015

Christopher Porter, MD/ Jill Slansky, PhD

Leukemia-cell Calcineurin as a central mediator of immune evasion

                    $60,000

2014

Maranke Koster, PhD

Consequences of TP63 loss on human skin squamous cell carcinogenesis

                    $30,000

2014

John Tentler, PhD

Cancer Research Summer Fellowship Program

                    $30,000

2014

Jing Hong Wang, PhD

A Novel Approach to Reveal the Impact of Genetic Mutations on Cancer Genome Stability

                    $30,000

2014

James Hagman, PhD

Functional analysis of EBF1:PDGFRB, a novel oncoprotein

                    $30,000

2014

Carol Sartorius, PhD

Quiescent estrogen receptor positive cells as a source of breast cancer recurrence

                  $30,000

2014

bottom of page